AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
CIPROFLOXACIN 500.000 Mg ;
11 registrations across 1 African market— 11 active
Markets with CIPROFLOXACIN 500.000 Mg ;
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| CIPRO 500 mg Film Coated Tablets | 🇪🇬Egypt | MEMPHIS for pharmaceuticals and chemical industries | active | — |
| CIPROFLOXIRAZ 500 mg Film Coated Tablets | 🇪🇬Egypt | Nali pharma international for Pharmaceutical Industries and Trade | active | — |
| CIPROMEGA. Extended Release Film Coated Tablets | 🇪🇬Egypt | Mash for pharmaceutical Industries and cosmetic - mash premiere | active | — |
| ECACIPROFLOX 500mg Film Coated Tablets | 🇪🇬Egypt | Egyptian Canadian Pharmacetical (923) | active | — |
| NUCIPROZA Film Coated Tablets | 🇪🇬Egypt | Spimaco Misr for pharmaceutical industries | active | — |
| NUCIPROZA Film Coated Tablets | 🇪🇬Egypt | Spimaco Misr for pharmaceutical industries | active | — |
| CIPROMEGA. Extended Release Film Coated Tablets | 🇪🇬Egypt | Mash for pharmaceutical Industries and cosmetic - mash premiere | active | — |
| ECACIPROFLOX 500mg Film Coated Tablets | 🇪🇬Egypt | Egyptian Canadian Pharmacetical (923) | active | — |
| CIPROFLOXIRAZ 500 mg Film Coated Tablets | 🇪🇬Egypt | Nali pharma international for Pharmaceutical Industries and Trade | active | — |
| CIPRO 500 mg Film Coated Tablets | 🇪🇬Egypt | MEMPHIS for pharmaceuticals and chemical industries | active | — |
| CIPROMAX Film Coated Tablets | 🇪🇬Egypt | Spimaco-Egypt | active | — |
CIPROFLOXACIN 500.000 Mg ; in Africa — Regulatory Overview
CIPROFLOXACIN 500.000 Mg ; is registered across 1 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.
Of the 11 registrations, 11 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.